Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 25. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1448ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineEKVXNANAXTT assayLog10 pfu/cell30% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1456ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.294 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1462ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.440NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1468ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.660NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1474ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.124 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1480ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.216NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1486ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (56.06 +/- 15.87 micromolar, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.374NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1492ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.955NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1498ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.559NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1504ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.328NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1510ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.933NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1516ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1522ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (29.34+/- 6.62, ratio is 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.610NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1528ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1534ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1540ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1546ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1552ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1558ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1564ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 3.275NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1570ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 1.927NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1576ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 1.134NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1582ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.193NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1588ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.651NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1594ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineEKVXNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 2.192NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950